Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 76

1.

[Deep brain stimulation in Parkinson's disease: better balanced through consideration of the psychosocial consequences].

Duits AA, Munneke M, Aalderink CJ, Kuijf ML, Bloem BR, Esselink RAJ.

Ned Tijdschr Geneeskd. 2019 Aug 6;163. pii: D3838. Dutch.

PMID:
31386314
2.

Serum NFL discriminates Parkinson disease from atypical parkinsonisms.

Marques TM, van Rumund A, Oeckl P, Kuiperij HB, Esselink RAJ, Bloem BR, Otto M, Verbeek MM.

Neurology. 2019 Mar 26;92(13):e1479-e1486. doi: 10.1212/WNL.0000000000007179. Epub 2019 Feb 27.

PMID:
30814322
3.

α-Synuclein real-time quaking-induced conversion in the cerebrospinal fluid of uncertain cases of parkinsonism.

van Rumund A, Green AJE, Fairfoul G, Esselink RAJ, Bloem BR, Verbeek MM.

Ann Neurol. 2019 May;85(5):777-781. doi: 10.1002/ana.25447. Epub 2019 Mar 25.

4.

Cerebrospinal Fluid Galectin-1 Levels Discriminate Patients with Parkinsonism from Controls.

Marques TM, van Rumund A, Bruinsma IB, Wessels HJCT, Gloerich J, Esselink RAJ, Bloem BR, Kuiperij HB, Verbeek MM.

Mol Neurobiol. 2019 Jul;56(7):5067-5074. doi: 10.1007/s12035-018-1426-9. Epub 2018 Nov 21.

5.

Brain atrophy and strategic lesion location increases risk of parkinsonism in cerebral small vessel disease.

Bergkamp MI, Tuladhar AM, van der Holst HM, van Leijsen EMC, Ghafoorian M, van Uden IWM, van Dijk EJ, Norris DG, Platel B, Esselink RAJ, Leeuw FE.

Parkinsonism Relat Disord. 2019 Apr;61:94-100. doi: 10.1016/j.parkreldis.2018.11.010. Epub 2018 Nov 8.

PMID:
30448096
6.

Toxic Leukoencephalopathy Presenting as Lethal Catatonia.

van Esch AMJ, Fest A, Hoffland BS, Janzing JGE, Steens SCA, Esselink RAJ, Schellekens AFA.

J Addict Med. 2019 May/Jun;13(3):241-244. doi: 10.1097/ADM.0000000000000470.

PMID:
30394993
7.

Enhanced motivation of cognitive control in Parkinson's disease.

Timmer MHM, Aarts E, Esselink RAJ, Cools R.

Eur J Neurosci. 2018 Sep;48(6):2374-2384. doi: 10.1111/ejn.14137. Epub 2018 Sep 16.

8.

Mechanisms Underlying Dopamine-Induced Risky Choice in Parkinson's Disease With and Without Depression (History).

Timmer MHM, Sescousse G, Esselink RAJ, Piray P, Cools R.

Comput Psychiatr. 2018 Feb 1;2:11-27. doi: 10.1162/CPSY_a_00011. eCollection 2018 Feb.

9.

Parkinson's Disease Diagnostic Observations (PADDO): study rationale and design of a prospective cohort study for early differentiation of parkinsonism.

van Rumund A, Aerts MB, Esselink RAJ, Meijer FJA, Verbeek MM, Bloem BR.

BMC Neurol. 2018 May 16;18(1):69. doi: 10.1186/s12883-018-1072-x.

10.

Clinical correlates of cerebral white matter abnormalities in patients with Parkinson's disease.

Ten Harmsen BL, van Rumund A, Aerts MB, Bergkamp MI, Esselink RAJ, Richard E, Meijer FJA, Bloem BR, van Wamelen DJ.

Parkinsonism Relat Disord. 2018 Apr;49:28-33. doi: 10.1016/j.parkreldis.2017.12.029. Epub 2017 Dec 27.

PMID:
29306636
11.

What a neurologist should know about depression in Parkinson's disease.

Timmer MHM, van Beek MHCT, Bloem BR, Esselink RAJ.

Pract Neurol. 2017 Oct;17(5):359-368. doi: 10.1136/practneurol-2017-001650. Epub 2017 Jul 24. Review.

PMID:
28739866
12.

Reward learning deficits in Parkinson's disease depend on depression.

Timmer MHM, Sescousse G, van der Schaaf ME, Esselink RAJ, Cools R.

Psychol Med. 2017 Oct;47(13):2302-2311. doi: 10.1017/S0033291717000769. Epub 2017 Apr 4.

PMID:
28374660
13.

Clinical Application of Brain MRI in the Diagnostic Work-up of Parkinsonism.

Meijer FJA, Goraj B, Bloem BR, Esselink RAJ.

J Parkinsons Dis. 2017;7(2):211-217. doi: 10.3233/JPD-150733. Review.

14.

MicroRNAs in Cerebrospinal Fluid as Potential Biomarkers for Parkinson's Disease and Multiple System Atrophy.

Marques TM, Kuiperij HB, Bruinsma IB, van Rumund A, Aerts MB, Esselink RAJ, Bloem BR, Verbeek MM.

Mol Neurobiol. 2017 Dec;54(10):7736-7745. doi: 10.1007/s12035-016-0253-0. Epub 2016 Nov 14.

15.

Nigrosome-1 on Susceptibility Weighted Imaging to Differentiate Parkinson's Disease From Atypical Parkinsonism: An In Vivo and Ex Vivo Pilot Study.

Meijer FJ, Steens SC, van Rumund A, van Cappellen van Walsum AM, Küsters B, Esselink RA, Verbeek MM, Bloem BR, Goraj B.

Pol J Radiol. 2016 Aug 3;81:363-9. doi: 10.12659/PJR.897090. eCollection 2016.

16.

Drug-associated progressive multifocal leukoencephalopathy: a clinical, radiological, and cerebrospinal fluid analysis of 326 cases.

Maas RP, Muller-Hansma AH, Esselink RA, Murk JL, Warnke C, Killestein J, Wattjes MP.

J Neurol. 2016 Oct;263(10):2004-21. doi: 10.1007/s00415-016-8217-x. Epub 2016 Jul 11.

17.

A LRSAM1 mutation links Charcot-Marie-Tooth type 2 to Parkinson's disease.

Aerts MB, Weterman MA, Quadri M, Schelhaas HJ, Bloem BR, Esselink RA, Baas F, Bonifati V, van de Warrenburg BP.

Ann Clin Transl Neurol. 2015 Dec 22;3(2):146-9. doi: 10.1002/acn3.281. eCollection 2016 Feb.

18.

Sudden Death: An Uncommon Occurrence in Dementia with Lewy Bodies.

Molenaar JP, Wilbers J, Aerts MB, Leijten QH, van Dijk JG, Esselink RA, Bloem BR.

J Parkinsons Dis. 2016;6(1):53-5. doi: 10.3233/JPD-150755.

PMID:
26891177
19.

Profile of Neuropsychiatric Symptoms in Parkinson's Disease: Surgical Candidates Compared to Controls.

Lamberti VM, Pereira B, Lhommée E, Bichon A, Schmitt E, Pelissier P, Kistner A, Fraix V, Castrioto A, Esselink RA, Durif F, Krack P.

J Parkinsons Dis. 2016;6(1):133-42. doi: 10.3233/JPD-150698.

PMID:
26889631
20.

Cerebral small vessel disease and incident parkinsonism: The RUN DMC study.

van der Holst HM, van Uden IW, Tuladhar AM, de Laat KF, van Norden AG, Norris DG, van Dijk EJ, Esselink RA, Platel B, de Leeuw FE.

Neurology. 2015 Nov 3;85(18):1569-77. doi: 10.1212/WNL.0000000000002082. Epub 2015 Oct 7.

21.

Is there still need for microelectrode recording now the subthalamic nucleus can be well visualized with high field and ultrahigh MR imaging?

Kocabicak E, Alptekin O, Ackermans L, Kubben P, Kuijf M, Kurt E, Esselink R, Temel Y.

Front Integr Neurosci. 2015 Aug 11;9:46. doi: 10.3389/fnint.2015.00046. eCollection 2015. No abstract available.

22.

Differential optimal dopamine levels for set-shifting and working memory in Parkinson's disease.

Fallon SJ, Smulders K, Esselink RA, van de Warrenburg BP, Bloem BR, Cools R.

Neuropsychologia. 2015 Oct;77:42-51. doi: 10.1016/j.neuropsychologia.2015.07.031. Epub 2015 Jul 31.

PMID:
26239947
23.

CSF Neurofilament Light Chain but not FLT3 Ligand Discriminates Parkinsonian Disorders.

Herbert MK, Aerts MB, Beenes M, Norgren N, Esselink RA, Bloem BR, Kuiperij HB, Verbeek MM.

Front Neurol. 2015 May 5;6:91. doi: 10.3389/fneur.2015.00091. eCollection 2015.

24.

Conventional 3T brain MRI and diffusion tensor imaging in the diagnostic workup of early stage parkinsonism.

Meijer FJ, van Rumund A, Tuladhar AM, Aerts MB, Titulaer I, Esselink RA, Bloem BR, Verbeek MM, Goraj B.

Neuroradiology. 2015 Jul;57(7):655-69. doi: 10.1007/s00234-015-1515-7. Epub 2015 Apr 7.

25.

Freezing of gait in Parkinson's disease is related to impaired motor switching during stepping.

Smulders K, Esselink RA, Bloem BR, Cools R.

Mov Disord. 2015 Jul;30(8):1090-7. doi: 10.1002/mds.26133. Epub 2015 Jan 16.

PMID:
25641204
26.

Ancillary investigations to diagnose parkinsonism: a prospective clinical study.

Aerts MB, Esselink RA, Abdo WF, Meijer FJ, Drost G, Norgren N, Janssen MJ, Borm GF, Bloem BR, Verbeek MM.

J Neurol. 2015 Feb;262(2):346-56. doi: 10.1007/s00415-014-7568-4. Epub 2014 Nov 9.

PMID:
25381460
27.

Susceptibility-weighted imaging improves the diagnostic accuracy of 3T brain MRI in the work-up of parkinsonism.

Meijer FJ, van Rumund A, Fasen BA, Titulaer I, Aerts M, Esselink R, Bloem BR, Verbeek MM, Goraj B.

AJNR Am J Neuroradiol. 2015 Mar;36(3):454-60. doi: 10.3174/ajnr.A4140. Epub 2014 Oct 22.

28.

Trait impulsivity is associated with the risk of falls in Parkinson's disease.

Smulders K, Esselink RA, Cools R, Bloem BR.

PLoS One. 2014 Mar 7;9(3):e91190. doi: 10.1371/journal.pone.0091190. eCollection 2014.

29.

Addition of MHPG to Alzheimer's disease biomarkers improves differentiation of dementia with Lewy bodies from Alzheimer's disease but not other dementias.

Herbert MK, Aerts MB, Kuiperij HB, Claassen JAHR, Spies PE, Esselink RAJ, Bloem BR, Verbeek MM.

Alzheimers Dement. 2014 Jul;10(4):448-455.e2. doi: 10.1016/j.jalz.2013.05.1775. Epub 2013 Nov 13.

PMID:
24239248
30.

Postural inflexibility in PD: does it affect compensatory stepping?

Smulders K, Esselink RA, De Swart BJ, Geurts AC, Bloem BR, Weerdesteyn V.

Gait Posture. 2014 Feb;39(2):700-6. doi: 10.1016/j.gaitpost.2013.10.003. Epub 2013 Oct 10.

PMID:
24189111
31.

CSF levels of DJ-1 and tau distinguish MSA patients from PD patients and controls.

Herbert MK, Eeftens JM, Aerts MB, Esselink RA, Bloem BR, Kuiperij HB, Verbeek MM.

Parkinsonism Relat Disord. 2014 Jan;20(1):112-5. doi: 10.1016/j.parkreldis.2013.09.003. Epub 2013 Sep 12.

PMID:
24075122
32.

A cross-sectional multicenter study of cognitive and behavioural features in multiple system atrophy patients of the parkinsonian and cerebellar type.

Siri C, Duerr S, Canesi M, Delazer M, Esselink R, Bloem BR, Gurevich T, Balas M, Giladi N, Santacruz P, Marti F, Tolosa E, Rubino A, Meco G, Poewe W, Pezzoli G, Wenning G, Antonini A.

J Neural Transm (Vienna). 2013 Apr;120(4):613-8. doi: 10.1007/s00702-013-0997-x. Epub 2013 Mar 6.

PMID:
23462799
33.

Involvement of specific executive functions in mobility in Parkinson's disease.

Smulders K, van Nimwegen M, Munneke M, Bloem BR, Kessels RP, Esselink RA.

Parkinsonism Relat Disord. 2013 Jan;19(1):126-8. doi: 10.1016/j.parkreldis.2012.06.010. Epub 2012 Jul 5.

PMID:
22771282
34.

Improving the diagnostic accuracy in parkinsonism: a three-pronged approach.

Aerts MB, Esselink RA, Post B, van de Warrenburg BP, Bloem BR.

Pract Neurol. 2012 Apr;12(2):77-87. doi: 10.1136/practneurol-2011-000132. Review.

PMID:
22450452
35.

Assessment of dual tasking has no clinical value for fall prediction in Parkinson’s disease.

Smulders K, Esselink RA, Weiss A, Kessels RP, Geurts AC, Bloem BR.

J Neurol. 2012 Sep;259(9):1840-7.

36.

Contribution of routine brain MRI to the differential diagnosis of parkinsonism: a 3-year prospective follow-up study.

Meijer FJ, Aerts MB, Abdo WF, Prokop M, Borm GF, Esselink RA, Goraj B, Bloem BR.

J Neurol. 2012 May;259(5):929-35. doi: 10.1007/s00415-011-6280-x. Epub 2011 Oct 19.

37.

CSF tau, Aβ42, and MHPG differentiate dementia with Lewy bodies from Alzheimer's disease.

Aerts MB, Esselink RA, Claassen JA, Abdo WF, Bloem BR, Verbeek MM.

J Alzheimers Dis. 2011;27(2):377-84. doi: 10.3233/JAD-2011-110482.

PMID:
21841257
38.

Prevalence of depression in Parkinson's disease: effects of disease stage, motor subtype and gender.

van der Hoek TC, Bus BA, Matui P, van der Marck MA, Esselink RA, Tendolkar I.

J Neurol Sci. 2011 Nov 15;310(1-2):220-4. doi: 10.1016/j.jns.2011.07.007. Epub 2011 Jul 29.

PMID:
21802694
39.

Diagnostic challenges in parkinsonism.

Aerts M, Meijer FJ, Verbeek M, Esselink R, Bloem BR.

Expert Rev Neurother. 2011 Aug;11(8):1099-101. doi: 10.1586/ern.11.96. No abstract available.

PMID:
21797648
40.

Lower vascular tone and larger plasma volume in Parkinson's disease with orthostatic hypotension.

Groothuis JT, Esselink RA, Seeger JP, van Aalst MJ, Hopman MT, Bloem BR.

J Appl Physiol (1985). 2011 Aug;111(2):443-8. doi: 10.1152/japplphysiol.00069.2011. Epub 2011 Jun 2.

41.

How to perform a preplanned process evaluation for complex interventions in geriatric medicine: exemplified with the process evaluation of a complex falls-prevention program for community-dwelling frail older fallers.

Reelick MF, Faes MC, Esselink RA, Kessels RP, Olde Rikkert MG.

J Am Med Dir Assoc. 2011 Jun;12(5):331-6. doi: 10.1016/j.jamda.2011.01.006. Epub 2011 Feb 17.

PMID:
21450245
42.

Multifactorial fall prevention for pairs of frail community-dwelling older fallers and their informal caregivers: a dead end for complex interventions in the frailest fallers.

Faes MC, Reelick MF, Melis RJ, Borm GF, Esselink RA, Rikkert MG.

J Am Med Dir Assoc. 2011 Jul;12(6):451-8. doi: 10.1016/j.jamda.2010.11.006. Epub 2010 Dec 24.

PMID:
21450224
43.

Causes and consequences of cerebral small vessel disease. The RUN DMC study: a prospective cohort study. Study rationale and protocol.

van Norden AG, de Laat KF, Gons RA, van Uden IW, van Dijk EJ, van Oudheusden LJ, Esselink RA, Bloem BR, van Engelen BG, Zwarts MJ, Tendolkar I, Olde-Rikkert MG, van der Vlugt MJ, Zwiers MP, Norris DG, de Leeuw FE.

BMC Neurol. 2011 Feb 28;11:29. doi: 10.1186/1471-2377-11-29.

44.

The fall telephone for falls assessment in frail older persons; feasibility, reliability, and validity.

Reelick MF, Faes MC, Lenferink A, Esselink RA, Olde Rikkert MG.

J Am Geriatr Soc. 2011 Feb;59(2):372-3. doi: 10.1111/j.1532-5415.2011.02900.x. No abstract available.

PMID:
21314659
45.

CSF α-synuclein does not differentiate between parkinsonian disorders.

Aerts MB, Esselink RA, Abdo WF, Bloem BR, Verbeek MM.

Neurobiol Aging. 2012 Feb;33(2):430.e1-3. doi: 10.1016/j.neurobiolaging.2010.12.001. Epub 2011 Jan 13.

46.

Increased intra-individual variability in stride length and reaction time in recurrent older fallers.

Reelick MF, Kessels RP, Faes MC, Weerdesteyn V, Esselink RA, Olde Rikkert MG.

Aging Clin Exp Res. 2011 Oct-Dec;23(5-6):393-9. doi: 10.3275/7327. Epub 2010 Nov 2.

PMID:
21048423
47.

Developing and evaluating complex healthcare interventions in geriatrics: the use of the medical research council framework exemplified on a complex fall prevention intervention.

Faes MC, Reelick MF, Esselink RA, Rikkert MG.

J Am Geriatr Soc. 2010 Nov;58(11):2212-21. doi: 10.1111/j.1532-5415.2010.03108.x. Epub 2010 Oct 5.

PMID:
21039367
48.

Cerebrospinal fluid tau and phosphorylated tau protein are elevated in corticobasal syndrome.

Aerts MB, Esselink RA, Bloem BR, Verbeek MM.

Mov Disord. 2011 Jan;26(1):169-73. doi: 10.1002/mds.23341. Epub 2010 Sep 10.

PMID:
20836136
49.

Qualitative study on the impact of falling in frail older persons and family caregivers: foundations for an intervention to prevent falls.

Faes MC, Reelick MF, Joosten-Weyn Banningh LW, Gier Md, Esselink RA, Olde Rikkert MG.

Aging Ment Health. 2010 Sep;14(7):834-42. doi: 10.1080/13607861003781825.

PMID:
20635232
50.

International study on the psychometric attributes of the non-motor symptoms scale in Parkinson disease.

Martinez-Martin P, Rodriguez-Blazquez C, Abe K, Bhattacharyya KB, Bloem BR, Carod-Artal FJ, Prakash R, Esselink RA, Falup-Pecurariu C, Gallardo M, Mir P, Naidu Y, Nicoletti A, Sethi K, Tsuboi Y, van Hilten JJ, Visser M, Zappia M, Chaudhuri KR.

Neurology. 2009 Nov 10;73(19):1584-91. doi: 10.1212/WNL.0b013e3181c0d416.

PMID:
19901251

Supplemental Content

Loading ...
Support Center